De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma. - Xu D; Gao Y; Liu S; Yin S; Hu T; Deng H; Zhang T; Hegedüs B; Marti TM; Dorn P; Liang SQ; Schmid RA; et al. (EMBO molecular medicine, 2025)